Article

Can We Afford to Ignore the $600 Billion a Year Cost of Chronic Pain?

Roger B. Fillingim, PhD, president of the American Pain Society is one advocate speaking out about the problem faced by patients who suffer from chronic pain, defined as being present for 3-months or more. But he's not the only expert who is talking about finding better ways to help people in pain.

Fillingim says funding for research for better treatments is an unmet need that can no longer be ignored.

Fillingim points out chronic pain costs more than $600 billion a year for treatment and lost work time, yet grants awarded by the National Institutes of Health (NIH) account for just 1 percent of research.

Roger B. Fillingim, PhD, president of the American Pain Society is one advocate speaking out about the problem faced by patients who suffer from chronic pain, defined as being present for 3-months or more. But he's not the only expert who is talking about finding better ways to help people in pain.Yet another recent finding suggests when it comes to treating uncomplicated back pain, physicians are willing to order costly imaging tests and prescribe expensive medications to patients.

Read the full story here: http://bit.ly/1cvH5WB

Source: Emax Health

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
David Awad, PharmD, BCOP
Merrill H. Stewart, MD
David Awad, PharmD, BCOP
Coral Omene, MD, PhD, sitting for a vieo interview
Coral Omene, MD, PhD, sitting for a vieo interview
David Awad, PharmD, BCOP
Screenshot of Coral Omene, MD, PhD
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy (AMCP)
Eileen Peng, PharmD, sitting for a video interview
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo